Board-certified dermatologist discusses common types of hair loss seen in women with darker skin tones
NEW ORLEANS, March 17, 2023 /PRNewswire/ -- Hair loss in women can be emotionally devastating and may negatively impact quality of life, and new research suggests that it can also be associated with having other common medical conditions. A board-certified dermatologist at the American Academy of Dermatology's Annual Meeting in New Orleans will discuss the types of hair loss seen in women with darker skin tones, common types of medical conditions associated with hair loss, and hair loss treatment options.
"Research shows that women who experience hair loss can also have other medical conditions like diabetes, acne, and breast cancer," said board-certified dermatologist Valerie D. Callender, MD, FAAD, professor of dermatology at Howard University College of Medicine. "By recognizing the signs of hair loss and seeing your dermatologist as soon as possible, you may be able to limit the progression, hold on to the hair you have, and discover any other underlying medical conditions you may have."
Central centrifugal cicatricial alopecia (CCCA), which causes hair loss in the center, or crown, of the scalp, is the most common type of hair loss seen in women with darker skin tones. It is estimated to affect nearly 15% of Black women1, says Dr. Callender.
Early detection is important to preserve and protect your hair because CCCA can cause scarring by destroying hair folliclesthe tiny openings from which your hair grows. While it's possible to regrow some hair, once the hair follicle scars completely, regrowing hair becomes difficult and hair loss can be permanent.
A board-certified dermatologist can diagnose the type of hair loss you have and work with you to determine the best course of treatment for CCCA, which can include antibiotics, topical steroid medication, or corticosteroid injections. These medications may give patients relief from the pain, tenderness, and itching they're feeling in an affected area, as well as prevent scarring from getting worse.
Story continues
Conditions such as breast cancer, high cholesterol, diabetes, and high blood pressure2-3 are common among Black women with CCCA, says Dr. Callender. If you have CCCA, your dermatologist may be able to tell you if the other symptoms you're experiencing are caused by a dermatologic condition, or if they are a symptom of another disease.
Another common type of hair loss is female pattern hair loss, which affects millions of women of all skin tones. In female pattern hair loss, the hair thins mainly on the top of the scalp, and it usually starts with a widening of the center hair part. This type of hair loss is hereditary, and many women who have female pattern hair loss also have acne4 due to an increase in hormones, says Dr. Callender. While acne is more common in the early stages of female pattern hair loss, menopause and high blood pressure are common as female pattern hair loss progresses.
Minoxidil is a common treatment option for female pattern hair loss because it has been shown to reduce hair loss, stimulate hair growth, and strengthen existing strands of hair. Although minoxidil can be found in products at the drugstore, it's important to consult with a board-certified dermatologist as your hair loss may need to be treated with a higher dosage that is only available with a prescription. Your dermatologist can also advise you on how to apply the treatment to your scalp.
While braids, a ponytail, or an updo can look great, Dr. Callender says hairstyles that tightly pull the hair can cause traction alopecia, which is a common type of hair loss in women with darker skin tones due to hair styling.
"One of the first things I ask my patients who have a history of braids is if it hurts when their hair is braided," said Dr. Callender. "Getting your hair done shouldn't hurt, so if they have pain, it's an indicator that they could be developing traction alopecia."
Fortunately, there are options that allow a person to keep their sense of style without losing their hair. Loosening up the hairstyle, avoiding frequently wearing hairstyles that pull on your hair, and changing hairstyles can all help prevent traction alopecia.
It is especially important for women with any type of hair loss to consider the ingredients in their products. Women with darker skin tones, particularly those of African descent, have hair that tends to be coarse, dry, and fragile, says Dr. Callender. Some of the shampoos for dandruff and other scalp disorders can further dry out hair, leading to breakage. Patients with darker skin tones should use shampoos and hair products with ingredients that moisturize their hair such as vitamins A and E, jojoba oil, and shea butter.
"When treatments are not effective to prevent hair loss, a permanent solution is to consider a hair transplant, which creates natural-looking results," said Dr. Callender. "Hair transplants are most effective in patients with traction alopecia and female pattern hair loss. While patients with CCCA aren't always ideal candidates for a hair transplant due to scarring, it is possible for them to have success. A board-certified dermatologist can determine if a hair transplant is the right option."
Board-certified dermatologists are the experts in the diagnosis and treatment of hair loss. To find a board-certified dermatologist in your area, visit aad.org/findaderm.
More InformationHair loss resource centerCentral centrifugal cicatricial alopeciaFemale pattern hair lossTraction alopecia
About the AADHeadquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more than 20,800 physicians worldwide, the AAD is committed to advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair, and nails; advocating high standards in clinical practice, education and research in dermatology; and supporting and enhancing patient care because skin, hair, and nail conditions can have a serious impact on your health and well-being. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow @AADskin on Facebook, Pinterest and YouTube and @AADskin1 on Instagram.
Editor's note: The AAD does not promote or endorse any products or services. This content is intended as editorial content and should not be embedded with any paid, sponsored or advertorial content as it could be perceived as an AAD endorsement.
1Aguh, Crystal and Amy McMichael. "Central Centrifugal Cicatricial Alopecia." JAMA Dermatology, vol. 156, no. 9, 1 Sept. 2020, p. 1036, https://doi.org/10.1001/jamadermatol.2020.1859.2 Comorbidities in patients with central centrifugal cicatricial alopecia: A retrospective chart review of 53 patients Leung, Bonnie et al. Journal of the American Academy of Dermatology, Volume 88, Issue 2, 461 4633Association of breast and colorectal cancer in patients with central centrifugal cicatricial alopecia: A cross-sectional, pilot study Brown-Korsah, JessicaRoche, Fritzlaine C.Taylor, Susan C. et al. Journal of the American Academy of Dermatology, Volume 85, Issue 3, AB744The comparison of demographics and comorbidities of female pattern hair loss according to the clinical subtype and stage zkoca, Defne et al. Journal of the American Academy of Dermatology, Volume 87, Issue 4, 779 - 783
Cision
View original content:https://www.prnewswire.com/news-releases/american-academy-of-dermatology-research-suggests-connection-between-hair-loss-in-women-and-other-diseases-301775039.html
SOURCE American Academy of Dermatology
See the original post here:
- TikTok dermfluencers have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week -... - November 20th, 2024 [November 20th, 2024]
- $500,000 Pay, Predictable Hours: How Dermatology Became the It Job in Medicine - The Wall Street Journal - November 20th, 2024 [November 20th, 2024]
- Empowering Dermatology PAs Through Education and Career Support - Dermatology Times - November 20th, 2024 [November 20th, 2024]
- U.S. Dermatology Partners Announces the Opening of Stephenville, Texas Office - PR Web - November 20th, 2024 [November 20th, 2024]
- $500,000 Pay, Predictable Hours: How Dermatology Became the It Job in Medicine - Yahoo! Voices - November 20th, 2024 [November 20th, 2024]
- FRONTIER-2 Study Evaluates Safety and Efficacy of Tozorakimab in Patients with AD - Dermatology Times - November 20th, 2024 [November 20th, 2024]
- Improving Care and Innovations in Vitiligo and Atopic Dermatitis: Part 1 - Dermatology Times - November 20th, 2024 [November 20th, 2024]
- In the United States, the dermatology concentration of doctors is also noticeable.The Wall Street Jo.. - - November 20th, 2024 [November 20th, 2024]
- Dermatology Diagnostic Devices and Therapeutics Market Size, Trends and Industry Growth Forecast to 2032 - openPR - November 20th, 2024 [November 20th, 2024]
- POLL: What Topics Are You Looking Forward to at SDPA Fall 2024? - Dermatology Times - November 20th, 2024 [November 20th, 2024]
- Digital tool aims to tackle long dermatology waits - Health and Care News Scotland - November 20th, 2024 [November 20th, 2024]
- Is AI Coming for My Job?: Familiarizing Clinicians with AI Tools and Their Role in Dermatology - Dermatology Times - November 12th, 2024 [November 12th, 2024]
- Almiralls Nine-Month 2024 Results: Almirall Reports Strong Performance at Q3 2024 - Driven by Successful Commercial Execution of the Dermatology... - November 12th, 2024 [November 12th, 2024]
- Updates on the Latest Cosmetic Treatments in Medical Care - Dermatology Times - November 12th, 2024 [November 12th, 2024]
- Jenny Murase, MD: Emerging Therapies Bring Hope to Patients with Persistent Itch - Dermatology Times - November 12th, 2024 [November 12th, 2024]
- POLL: Are You Attending the Elevate-Derm West Conference? - Dermatology Times - November 12th, 2024 [November 12th, 2024]
- Memorial Health System is re-opening of Department of Dermatology - Parkersburg News - October 26th, 2024 [October 26th, 2024]
- Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Sun Pharma Announces Multiple Data Presentations Highlighting its Dermatology Portfolio to be Featured at the 2024 Fall Clinical Dermatology... - October 26th, 2024 [October 26th, 2024]
- What To Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD - MD Magazine - October 26th, 2024 [October 26th, 2024]
- Navigating Complexities and Unmet Needs of Chronic Hand Eczema - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Schweiger Dermatology Group Expands in Florida with the Acquisition of ClearlyDerm, Adding 5 New Offices in South Florida - PR Newswire - October 26th, 2024 [October 26th, 2024]
- Leo Pharma tells doctors to 'Talk to the Hand' in new dermatology campaign - FiercePharma - October 26th, 2024 [October 26th, 2024]
- Dermatology Partners To Expand Maryland Presence With New Westminster Clinic, Hosts Free Skin Cancer Screenings For Veterans On November 11 - citybiz - October 26th, 2024 [October 26th, 2024]
- Peter Lio, MD: The Latest Perspectives on Pathophysiology and Treatment of Eczema - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell... - October 26th, 2024 [October 26th, 2024]
- Dermatology Patients Taking Biologics are Wary About Most Vaccines - Medpage Today - October 13th, 2024 [October 13th, 2024]
- Safe and Effective: Upadacitinib Shows Promise in PN Treatment - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- SPONSORED: First Care, Heartland Dermatology team up again for free health screening event - Hays Post - October 13th, 2024 [October 13th, 2024]
- Global Dermatology Drugs Market to Worth Over US$ 50.42 Billion By 2032 | Astute Analytica - GlobeNewswire - October 13th, 2024 [October 13th, 2024]
- Working to Improve Mental Health - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- Bimekizumab Demonstrates Safety and Efficacy in Elderly Patients with Psoriasis - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- Analyzing Efficacy and Safety in Diverse Clinical Trials: New Roflumilast Data - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- UCB at EADV 2024: committed to advancing care in immuno-dermatology - UCB - October 2nd, 2024 [October 2nd, 2024]
- Positive Results Reported in Roflumilast 0.15% for AD Across Diverse Populations - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- Expert Insights Into Handling Treatment Challenges and Site-Specific Concerns in Vitiligo Management - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- Dermatology Excimer Laser Market is expected to Double Its Size - openPR - October 2nd, 2024 [October 2nd, 2024]
- InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and... - October 2nd, 2024 [October 2nd, 2024]
- Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD - MD Magazine - September 23rd, 2024 [September 23rd, 2024]
- Organon Moves Into Branded Dermatology With Dermavant Takeout - Scrip - September 23rd, 2024 [September 23rd, 2024]
- Dermatology Research Team Investigating the Most Common Disease Youve Never Heard About - University of Miami - September 23rd, 2024 [September 23rd, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress - Business Wire - September 23rd, 2024 [September 23rd, 2024]
- Hensin Tsao, MD, PhD: TIL Therapy and Neoadjuvant Treatment for Pigmented Lesions - Dermatology Times - September 23rd, 2024 [September 23rd, 2024]
- Derm In The News: September 8-14 - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Nearly half of FDA-authorized AI tools may be ineffective - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Dermatology Diagnostic Devices And Therapeutics Market - openPR - September 15th, 2024 [September 15th, 2024]
- Industry Deep Dive: Dermatology Devices Market Size, Share, and Growth Forecast with Emerging Trends through 2032 - openPR - September 15th, 2024 [September 15th, 2024]
- SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Veterinary Dermatology Drugs Market Global Latest Trends and Insights 2024 to 2031 - openPR - September 15th, 2024 [September 15th, 2024]
- Championing equity in skin of color dermatology - Fierce healthcare - August 5th, 2024 [August 5th, 2024]
- Derm In The News: July 28-August 3 - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Interview Intersection: Expert Interviews From July 2024 - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Generation Z, Millennials Exhibit Similar Subjective Perception of Atopic Dermatitis Disease Severity - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Long-Term Efficacy and Insights from POETYK PSO-1 Studies: Implications for Psoriasis Treatment - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Laurel Dermatology emphasizes the importance of sunscreen - WDAM - July 26th, 2024 [July 26th, 2024]
- The Interplay Between Sleep Disorders and Dermatology - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Latex Gloves and the Americans With Disabilities Act - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Advanced Practice Providers Share Insights at the 2024 Society for Pediatric Dermatology Annual Meeting - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Almiralls H1 2024 Results: Almirall Delivers Strong Performance in the First Half of 2024, Achieving Net Sales Growth of 6.7% Driven by Its European... - July 26th, 2024 [July 26th, 2024]
- Arcutis Submits sNDA for Roflumilast Foam to FDA for Scalp and Body Psoriasis - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Appier and SkinX Thailand Partner to Revolutionise Dermatology Services with AI - SME Magazine - July 26th, 2024 [July 26th, 2024]
- Diagnostic dermatology market to be valued at $43.4b by 2034 - Healthcare Asia - July 26th, 2024 [July 26th, 2024]
- FDNY Partners with American Academy of Dermatology to Provide Free Skin Cancer Checks - nyc.gov - June 1st, 2024 [June 1st, 2024]
- Day 1 Recap: 2024 Fall Clinical Dermatology Conference for PAs and NPs - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- Dermatology's Rosanne Paul discusses safety of foot peels - The Daily | Case Western Reserve University - June 1st, 2024 [June 1st, 2024]
- Sneak Peek: 2024 Fall Clinical Dermatology Conference for PAs and NPs - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- New Dermatology Center to Open at The Grand Resort's Med Spa - businessjournaldaily.com - June 1st, 2024 [June 1st, 2024]
- Dermatology Care of Alabama goes the extra mile to give the best care - Hoover Sun - June 1st, 2024 [June 1st, 2024]
- QUIZ RECAP: Treatment and Management of Skin Cancer - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- What to Know About Peptides, the Retinol Alternative Dermatologists Love | SELF - Self - June 1st, 2024 [June 1st, 2024]
- Reviewing Common and Prevalent Dermatoses in AAPI Patients - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- Dermatologists Advise Against Taking Bite Of Facial Cream - The Onion - June 1st, 2024 [June 1st, 2024]
- Prescription Dermatology Therapeutics Market Drivers And Restraints Identified Through SWOT Analysis 2030 - openPR - June 1st, 2024 [June 1st, 2024]
- Derm In The News: May 19-25 - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- What Gen Z Should Know About Sunscreen to Help Protect From Skin Cancer - The New York Times - June 1st, 2024 [June 1st, 2024]
- American Academy of Dermatology Association Statement on Reports on Counterfeit Injectables - Newswise - April 15th, 2024 [April 15th, 2024]
- Surface Area of IL-23's Epitope Influences Short- and Long-Term Responses for IL-23 Inhibitors in Plaque Psoriasis - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Atopic Dermatitis (Eczema): 5 Top Self-Care Tips - Everyday Health - April 15th, 2024 [April 15th, 2024]
- Derm In The News: April 7-13 - Dermatology Times - April 15th, 2024 [April 15th, 2024]